A new report commissioned by Health Research BC evaluates the current state of BC’s clinical trials ecosystem.

The report assesses BC’s overall competitiveness in clinical trials and compares it to other provinces. It acknowledges strengths such as BC’s world-class facilities and expertise, while noting opportunities to improve the province’s current underperformance in clinical trial investments and per capita funding.

The report also identifies challenges facing the clinical trials ecosystem, such as lengthy study start-up times, bureaucratic complexity, and underdeveloped infrastructure.

The report’s findings include key insights to enhance BC’s competitiveness:

  • establish an ecosystem convener
  • mandate centralized and harmonized review mechanisms
  • integrate clinical trials into clinical care
  • leverage health data

Health Research BC is one organization within the province’s clinical trials ecosystem. The organization looks forward to contributing activities and expertise within the mandate to those of other organizations to strengthen the clinical trials ecosystem in this province.

Related posts

  • Graphic for a position paper on strengthening research ethics in British Columbia. The text reads: Strengthening research ethics in British Columbia: A call for leadership and collective action. There is a button to read more and a mockup of the paper on the graphic, featuring a lime green colour scheme.

    New position paper calls for strong, sustainable research ethics in BC

    July 23, 2026

  • Cover page of BC's clinical trials strategy on the right, with text on the left: A new strategy for clinical trials in British Columbia: Three-year strategy.

    BC takes action to strengthen the clinical trials ecosystem

    June 18, 2026

  • An aerial shot of Moorecroft Regional Park, Nanoose Bay at Vancouver Island, British Columbia, Canada. The photo shows evergreen trees on a vibrant bay area, with ocean in the background. The skies and mostly clear with soft clouds.

    A more connected future for clinical trials in BC

    May 26, 2026